📰 Michael Olin News
Michael Olin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Olin. Real-time updates on events, politics, business and more.
December 6, 2023
/PRNewswire/ -- Pioneer Management Consulting announced today the launch of Pioneer Ventures Group, a new investment arm focused on funding companies...
August 27, 2023
Fourteen balloons sailed over the Aroostook River Saturday after launching from Johnson Road in Presque Isle.
August 26, 2023
Fourteen balloons sailed over the Aroostook River Saturday after launching from Johnson Road in Presque Isle.
August 22, 2023
What started with just a few balloons and minimal spectators has become a four-day extravaganza that draws 4,000 to 8,000 visitors.
April 16, 2023
A Nass writer investigates why and how students take leaves—and what it’s like to be gone.
January 12, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. New Treatment for Central Nervous System Tumors Enters Phase I Clinical Trials January 12, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--Jan 12, 2021-- OX2 Therapeutics, Inc., a privately held Minneapolis company, announces today that they treated their first patient in a phase one human trial of a new treatment developed to combat recurrent high-grade brain tumors. “This is a first-of-its kind immunotherap...
January 7, 2021
January 7, 2021 Elizabeth Neil Physicians and scientists at the University of Minnesota have opened a new brain cancer clinical trial and have treated their first patient. This Phase I, first-in-human trial is enrolling patients with a specific type of brain cancer, glioblastoma. The development for this innovative treatment is based on years of research from Michael Olin, PhD, and Christopher Moertel, MD, researchers in the University of Minnesota Medical School’s Division of Hemat...